Transparency in reporting of phase 3 cancer clinical trial results
- 13 December 2020
- journal article
- letter
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 60 (2) , 191-194
Abstract
Phase 3 clinical trials are widely recognized as the highest level of evidence to support a particular intervention/therapy in the medical literature. The ability to draw clinically meaningful conc...Keywords
Funding Information
- NIH (P30 CA016672)
- NIH (P30 CA016672)
This publication has 16 references indexed in Scilit:
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical TrialsAnnals of Internal Medicine, 2013
- Comparison of protocols and registry entries to published reports for randomised controlled trialsCochrane Database of Systematic Reviews, 2011
- Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocolsBMJ, 2008
- Statistics in Medicine — Reporting of Subgroup Analyses in Clinical TrialsNew England Journal of Medicine, 2007
- Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort studyBMJ, 2005
- Empirical Evidence for Selective Reporting of Outcomes in Randomized TrialsJAMA, 2004
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996
- Improving the quality of reporting of randomized controlled trials. The CONSORT statementJAMA, 1996
- Our Patient EarthNew England Journal of Medicine, 1990
- Editorial Review of Protocols for Clinical TrialsNew England Journal of Medicine, 1990